Recall of and reactions to a surgeon referral letter for BRCA genetic counseling among high-risk breast cancer patients

Annals of Surgical Oncology

Volumn 16, Issue 7, 2009, Pages 1973-1981

  Vadaparampil, Susan T ^a,b   Quinn, Gwendolyn P ^a,b   Miree, Cheryl A ^a   Brzosowicz, Jennifer ^a   Carter, Bradford ^a,b   Laronga, Christine ^a,b  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER PATIENT; CLINICAL ARTICLE; FEMALE; GENETIC COUNSELING; GROUNDED THEORY; HUMAN; INTERVIEW; ONCOGENE; PATIENT ATTITUDE; PATIENT REFERRAL; QUALITATIVE RESEARCH; RECALL;

ADULT; ATTITUDE TO HEALTH; BREAST NEOPLASMS; COMMUNICATION; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC COUNSELING; HUMANS; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT EDUCATION AS TOPIC; PHYSICIAN-PATIENT RELATIONS; REFERRAL AND CONSULTATION;

EID: 67649233101     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-009-0479-4     Document Type: Article

References (27)

1. Pieterse AH, Ausems MG, Van Dulmen AM, Beemer FA, Bensing JM. Initial cancer genetic counseling consultation: change in counselees' cognitions and anxiety, and association with addressing their needs and preferences. Am J Med Genet A. 2005; 137:27-35.
2. Schwartz MD, Lerman C, Brogan B, et al. Impact of BRCA1/ BRCA2 counseling and testing on newly diagnosed breast cancer patients. J Clin Oncol. 2004;22:1823-9.
3. Weitzel JN, McCaffrey SM, Nedelcu R, et al. Effect of genetic cancer risk assessment on surgical decisions at breast cancer diagnosis. Arch Surg. 2003;138:1323-8.
4. Brown KL, Hutchison R, Zinberg RE, McGovern MM. Referral and experience with genetic testing among women with early onset breast cancer. Genet Test. 2005;9:301-5.
5. Polednak AP. Do physicians discuss genetic testing with familyhistory- positive breast cancer patients? Conn Med. 1998;62:3-7.
6. Sweet KM, Bradley TL, Westman JA. Identification and referral of families at high risk for cancer susceptibility. J Clin Oncol. 2002;20:528-37.
7. Geer KP, Ropka ME, Cohn WF, Jones SM, Miesfeldt S. Factors influencing patients' decisions to decline cancer genetic counseling services. J Genet Couns. 2001;10:25-40.
8. Rahm AK, Sukhanova A, Ellis J, Mouchawar J. Increasing utilization of cancer genetic counseling services using a patient navigator model. J Genet Couns. 2007;16:171-7.
9. Westman J, Hampel H, Bradley T. Efficacy of a touchscreen computer based family cancer history questionnaire and subsequent cancer risk assessment. J Med Genet. 2000;37:354-60.
10. Armstrong K, Stopfer J, Calzone K, et al. What does my doctor think? Preferences for knowing the doctor's opinion among women considering clinical testing for BRCA1/2 mutations. Genet Test. 2002;6:115-8.
11. Schwartz MD, Lerman C, Brogan B, et al. Utilization of BRCA1/ BRCA2 mutation testing in newly diagnosed breast cancer patients. Cancer Epidemiol Biomarkers Prev. 2005;14:1003-7.
12. Stolier AJ, Fuhrman GM, Mauterer L, Bolton JS, Superneau DW. Initial experience with surgical treatment planning in the newly diagnosed breast cancer patient at high risk for BRCA-1 or BRCA- 2 mutation. Breast J. 2004;10:475-80.
13. Daly M, Axilbund JE, Bryant E, et al. The NCCN genetic/ familial high-risk assessment: breast and ovarian clinical practice guideline, version 1, 2009. Available at: http://www.nccn.org/ professionals/physician-gls/PDF/ genetics-screening.pdf. The most recent and complete version of guideline is available at www.nccn.org. Accessed April 22, 2009.
14. Matloff ET. The breast surgeon's role in BRCA1 and BRCA2 testing. Am J Surg. 2000;180:294-8.
15. The American Society of Breast Surgeons. BRCA genetic testing for patients with and without breast cancer. http://www.breast surgeons.org/ statements/brca.php. Accessed April 22, 2009.
16. Guest G, Bunce A, Johnson L. How many interviews are enough? An experiment with data saturation and variability. Field Methods. 2006;18:59-82.
17. Patton M. Qualitative Evaluation and Research Methods. Newbury Park, CA: Sage, 1990.
18. Krueger R. Analyzing and Reporting Focus Group Results. Thousand Oaks, CA: Sage, 1998.
19. Vadaparampil ST, Quinn GP, Brzosowicz J, Miree CA. Experiences of genetic counseling for BRCA1/2 among recently diagnosed breast cancer patients: a qualitative inquiry. J Psychosoc Oncol. 2008;26(4):33-52.
20. Briasoulis E, Roukos DH. Contralateral prophylactic mastectomy: mind the genetics. J Clin Oncol. 2008;26:1909-10.
21. Miesfeldt S, Cohn W, Ropka M, Jones S. Knowledge about breast cancer risk factors and hereditary breast cancer among earlyonset breast cancer survivors. Fam Cancer. 2001;1:135-41.
22. Daly MB. Tailoring breast cancer treatment to genetic status: the challenges ahead. J Clin Oncol. 2004;22:1776-7.
23. Palomares MR, Paz B, Weitzel JN. Genetic cancer risk assessment in the newly diagnosed breast cancer patient is useful and possible in practice. J Clin Oncol. 2005;23:3165-6.
24. Kieran S, Loescher LJ, Lim KH. The role of financial factors in acceptance of clinical BRCA genetic testing. Genet Test. 2007; 11:101-10.
25. Bottomley A, Jones L. Breast cancer care: women's experience. Eur J Cancer Care (Engl). 1997;6:124-32.
26. Velicer CM, Taplin S. Genetic testing for breast cancer: where are health care providers in the decision process? Genet Med. 2001; 3:112-9.
27. Wideroff L, Freedman AN, Olson L, et al. Physician use of genetic testing for cancer susceptibility: results of a national survey. Cancer Epidemiol Biomarkers Prev. 2003;12:295-303.